| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 113 |
| 1 | ASPIRIN | 112 |
| 2 | ASPIRIN 325 MG | 110 |
| 3 | ASPIRIN 81 MG | 110 |
| 4 | ACETAMINOPHEN 500MG | 101 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 101 |
| 6 | PAIN RELIEVER | 101 |
| 7 | LANSOPRAZOLE | 75 |
| 8 | RITUXIMAB | 75 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 64 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 27 | 0.0430 |
| 1 | SODIUM HYALURONATE | 5 | 0.0061 |
| 2 | CAPMATINIB | 14 | 0.0059 |
| 3 | PRAZOSIN | 24 | 0.0038 |
| 4 | FINERENONE | 12 | 0.0036 |
| 5 | PRAZOSIN HYDROCHLORIDE | 5 | 0.0036 |
| 6 | METHYLPREDNISOLONE ACETATE | 24 | 0.0030 |
| 7 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 40 | 0.0027 |
| 8 | PSYLLIUM HUSK | 3 | 0.0022 |
| 9 | CEFACLOR | 3 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 184 |
| 1 | Corticosteroid [EPC] | 115 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 114 |
| 3 | Vitamin C [EPC] | 107 |
| 4 | Proton Pump Inhibitor [EPC] | 102 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 82 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 80 |
| 7 | beta-Adrenergic Blocker [EPC] | 80 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 76 |
| 9 | Benzodiazepine [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 1 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 82 | 0.0008 |
| 4 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 11 | 0.0007 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 69 | 0.0006 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 8 | 0.0006 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 50 | 0.0006 |
| 9 | Estrogen Receptor Antagonist [EPC] | 20 | 0.0005 |